Epioxa and iDose drive growth as GKOS expands access and pipeline
Epioxa’s commercial launch is progressing as payer access expands and Photrexa sunset continues. iDose and core MIGS businesses are growing, with a pipeline and new screening device supporting future expansion, as management targets rapid patient ramp-up.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.